Atrophic Vaginitis clinical trials
The registry lists 45 studies for Atrophic Vaginitis across more than 10 countries. 7 are recruiting or about to start. 40 of them are mainly about Atrophic Vaginitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-01.
Get an email when these change. Save the Atrophic Vaginitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
EndoCeutics Inc. (6) · Stratpharma AG (4) · Herbarium Laboratorio Botanico Ltda (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Centre Hospitalier Universitaire de Nīmes (1) · Kerry Murphy (1) · Mylan Pharmaceuticals Inc (1) · Federal University of São Paulo (1)
What is being tested here
Drugs under test in Atrophic Vaginitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Aug 2027F-GYN for Vaginal Dryness and Vulvovaginal Atrophy · Biovico Sp. z o.o.
Who these studies take
Of the 4 Atrophic Vaginitis studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 0 (0%) take children under 18. 4 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (75%) | 0 (0%) |
| 30 | 3 (75%) | 0 (0%) |
| 40 | 3 (75%) | 0 (0%) |
| 50 | 4 (100%) | 0 (0%) |
| 65 | 4 (100%) | 0 (0%) |
| 75 | 3 (75%) | 0 (0%) |
| 85 | 3 (75%) | 0 (0%) |
Across all 45 studies, recruiting or not: 44% stop at 75 or younger and 11% at 65; 13% take children; 100% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 45 of 45. search them.
- F-GYN for Vaginal Dryness and Vulvovaginal AtrophyRecruitingNCT07701863Not applicable1 country
- Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIVNot yet recruitingNCT07526948Phase 41 country
- VALOR: Vaginal Atrophy & Long-term Observation of RecoveryRecruitingNCT05953090Not applicable1 country
- Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal WomenNot yet recruitingNCT06808347Phase 4
- Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer SurvivorsRecruitingNCT063054941 country
- Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal WomenRecruitingNCT04579991Not applicable1 country
- Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of MenopauseNot yet recruitingNCT06176820Phase 2/3
- ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser TherapyCompletedNCT07346287Phase 41 country
- Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal AtrophyCompletedNCT05058313Not applicable1 country
- Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal EstrogenCompletedNCT00984399Not applicable1 country
- Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis ConditionsCompletedNCT042196051 country
- LASER and Radiofrequency and Genitourinary Syndrome of MenopauseActive, not recruitingNCT04045379Not applicable1 country
- Accelerated Genital Tract Aging in HIV: Estradiol Clinical TrialCompletedNCT04079218Phase 41 country
- Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer PatientsCompletedNCT01370551Phase 12 countries
- Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen TherapyCompletedNCT03996603Phase 41 country
- Vaginal Progesterone Versus Placebo for the Treatment of Vaginal AtrophyWithdrawnNCT02460302Phase 21 country
- Estrogen and Platelet Rich Plasma in Treatment of Atrophic VaginitisStatus unknownNCT05118685Phase 11 country
- An Innovative Silicone Wound Dressing for the Management of Atrophic VaginitisCompletedNCT05432154Not applicable1 country
- a Flexible Wound Dressing for the Management of Genital Skin ConditionsCompletedNCT05396261Not applicable1 country
- A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic VaginitisCompletedNCT02195986Phase 31 country
- A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic VaginitisCompletedNCT02995694Phase 3
- Evaluation of Gynecological Acceptability of a Health Care ProductCompletedNCT04247022Not applicable1 country
- Vaginal and Urinary Microbiome TrialCompletedNCT02869165Phase 41 country
- Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast CancerWithdrawnNCT03740945Phase 3
- Evaluation of Gynecological Acceptability of 3 Health Care ProductsCompletedNCT04327947Not applicable1 country
- Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic VaginitisCompletedNCT03294538Phase 31 country
- Comparison of Vaginal Laser Therapy to Vaginal Estrogen TherapyCompletedNCT02691936Not applicable1 country
- Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic VaginitisStatus unknownNCT03981458Not applicable1 country
- Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse PatientsCompletedNCT03032848Phase 4
- Effect of PRP Injection in Releiving of Symptoms of Senile VaginitisStatus unknownNCT03898401Phase 11 country
- Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIVCompletedNCT02313545Phase 1/22 countries
- A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic VaginitisTerminatedNCT00816556Phase 31 country
- DHEA Against Vaginal Atrophy - Safety Study of 12 MonthsCompletedNCT01256671Phase 32 countries
- Topical DHEA Against Vaginal AtrophyCompletedNCT01846442Phase 32 countries
- DHEA Against Vaginal Atrophy - 3-Month Efficacy StudyCompletedNCT01256684Phase 32 countries
- Dehydroepiandrosterone (DHEA) Against Vaginal AtrophyCompletedNCT01358760Phase 32 countries
- Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With MenopauseCompletedNCT02013544Phase 32 countries
- The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic VaginitisStatus unknownNCT02733731Phase 11 country
- Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal DrynessCompletedNCT02029053Early Phase 11 country
- Microbiological Impact of an Intimate Cream and Its Suitability to Contribute to the Feeling of Softness and Freshness in the Intimate Area of WomenCompletedNCT02162160Phase 21 country
- The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ ProlapseCompletedNCT00803335Phase 31 country
- Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to PlaceboCompletedNCT01779947Phase 31 country
- Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic VaginitisCompletedNCT02014428Phase 41 country
- Study Evaluating Conjugated Estrogen Cream for Atrophic VaginitisCompletedNCT00137371Phase 32 countries
- Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic VaginitisCompletedNCT00167921Phase 11 country